ARBUTUS BIOPHARMA |
Kanada |
Gesundheit |
CA03879J1003 / A14XMD |
I9DN (Frankfurt) / ABUS (NASDAQ) |
FRA:I9DN, ETR:I9DN, I9DN:GR, NASDAQ:ABUS |
- |
https://www.arbutusbio.co.. |
582.89 Mio. EUR |
5.54 Mio. EUR |
-57.3 Mio. EUR |
-0.303 EUR |
4.85 Mio. EUR |
97.58 Mio. EUR |
15.1% / - |
- / - |
102.64 / 8.4 / - |
- / -79.02% |
- |
- / - |
- |
ARBUTUS |
16.07.25 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|